Crystalvue Medical Valuation
Is 6527 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
3/6Valuation Score 3/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 6527 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 6527 (NT$77.8) is trading below our estimate of fair value (NT$79.66)
Significantly Below Fair Value: 6527 is trading below fair value, but not by a significant amount.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 6527?
Other financial metrics that can be useful for relative valuation.
| What is 6527's n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | NT$1.97b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 2.1x |
| Enterprise Value/EBITDA | 12.3x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 6527's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 33.6x | ||
4161 Bioptik Technology Incorporation | 21.2x | n/a | NT$1.8b |
4106 Wellell | 18.4x | n/a | NT$2.8b |
6796 Medimaging Integrated Solution | 35.1x | n/a | NT$2.6b |
6815 Diamond Biotechnology | 59.7x | n/a | NT$2.7b |
6527 Crystalvue Medical | 19x | n/a | NT$2.0b |
Price-To-Earnings vs Peers: 6527 is good value based on its Price-To-Earnings Ratio (19x) compared to the peer average (33.6x).
Price to Earnings Ratio vs Industry
How does 6527's PE Ratio compare vs other companies in the TW Medical Equipment Industry?
Price-To-Earnings vs Industry: 6527 is good value based on its Price-To-Earnings Ratio (19x) compared to the TW Medical Equipment industry average (25.3x).
Price to Earnings Ratio vs Fair Ratio
What is 6527's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 19x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 6527's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.